These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17943167)

  • 1. Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels.
    Hatfield KJ; Hovland R; Øyan AM; Kalland KH; Ryningen A; Gjertsen BT; Bruserud Ø
    Leukemia; 2008 Feb; 22(2):287-93. PubMed ID: 17943167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release.
    Reikvam H; Hatfield KJ; Lassalle P; Kittang AO; Ersvaer E; Bruserud Ø
    Expert Opin Investig Drugs; 2010 Feb; 19(2):169-83. PubMed ID: 20050812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia.
    Schliemann C; Bieker R; Padro T; Kessler T; Hintelmann H; Buchner T; Berdel WE; Mesters RM
    Haematologica; 2006 Sep; 91(9):1203-11. PubMed ID: 16956819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.
    Hou HA; Chou WC; Lin LI; Tang JL; Tseng MH; Huang CF; Yao M; Chen CY; Tsay W; Tien HF
    Leuk Res; 2008 Jun; 32(6):904-12. PubMed ID: 17904634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators.
    Hatfield K; Øyan AM; Ersvaer E; Kalland KH; Lassalle P; Gjertsen BT; Bruserud Ø
    Br J Haematol; 2009 Jan; 144(1):53-68. PubMed ID: 19016730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.
    Lee CY; Tien HF; Hu CY; Chou WC; Lin LI
    Br J Cancer; 2007 Oct; 97(7):877-82. PubMed ID: 17848952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coculture of native human acute myelogenous leukemia blasts with fibroblasts and osteoblasts results in an increase of vascular endothelial growth factor levels.
    Glenjen NI; Hatfield K; Bruserud Ø
    Eur J Haematol; 2005 Jan; 74(1):24-34. PubMed ID: 15613103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation.
    Reikvam H; Hatfield KJ; Oyan AM; Kalland KH; Kittang AO; Bruserud O
    Eur J Haematol; 2010 Mar; 84(3):239-51. PubMed ID: 19922462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
    Ghosh K; Swaminathan S; Madkaikar M; Gupta M; Kerketta L; Vundinti B
    Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of δ-like ligand 4 and Notch1 in acute myeloid leukemia.
    Zhang J; Ma D; Ye J; Zang S; Lu F; Yang M; Qu X; Sun X; Ji C
    Oncol Rep; 2012 Oct; 28(4):1503-11. PubMed ID: 22858860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
    Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
    Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia.
    Bains A; Luthra R; Medeiros LJ; Zuo Z
    Am J Clin Pathol; 2011 Jan; 135(1):62-9. PubMed ID: 21173125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations.
    Devillier R; Gelsi-Boyer V; Brecqueville M; Carbuccia N; Murati A; Vey N; Birnbaum D; Mozziconacci MJ
    Am J Hematol; 2012 Jul; 87(7):659-62. PubMed ID: 22535592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features.
    Andersen MT; Andersen MK; Christiansen DH; Pedersen-Bjergaard J
    Leukemia; 2008 May; 22(5):951-5. PubMed ID: 18273044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
    Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
    Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of endothelial cell-associated molecules in AML cells.
    Watarai M; Miwa H; Shikami M; Sugamura K; Wakabayashi M; Satoh A; Tsuboi K; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
    Leukemia; 2002 Jan; 16(1):112-9. PubMed ID: 11840270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia.
    Ruan GR; Li JL; Qin YZ; Li LD; Xie M; Chang Y; Zhang Y; Liu YR; Jiang B; Chen SS; Huang XJ
    Ann Hematol; 2009 Feb; 88(2):159-66. PubMed ID: 18726096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
    Green CL; Koo KK; Hills RK; Burnett AK; Linch DC; Gale RE
    J Clin Oncol; 2010 Jun; 28(16):2739-47. PubMed ID: 20439648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia.
    Scholl S; Theuer C; Scheble V; Kunert C; Heller A; Mügge LO; Fricke HJ; Höffken K; Wedding U
    Eur J Haematol; 2008 Mar; 80(3):208-15. PubMed ID: 18081718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8.
    Ryningen A; Wergeland L; Glenjen N; Gjertsen BT; Bruserud O
    Leuk Res; 2005 Feb; 29(2):185-96. PubMed ID: 15607368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.